Highlights
Main publications
This list is a selected corpus, not the complete bibliography of every group member.
Lead
Disease
Year
2026
Corrigendum to "Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis" [European Journal of Internal Medicine 147 (2026) 106742].
Outcomes and Predictors of Treatment Response in Patients With Pure Lupus Membranous Nephropathy.
Soluble CD95L triggers Caspase-10-driven reactive oxygen species production in neutrophils and aggravates anti-neutrophil cytoplasmic antibody-vasculitis.
Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.
Antineutrophil Cytoplasmic Antibody-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes.
Kidney Outcomes With Rituximab Versus Cyclophosphamide in Crescentic ANCA-Associated Glomerulonephritis: Contextualizing Observational Findings.
Plasma exchange for severe alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: emulation of a target trial.
A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis.
Identification of Renal Transcripts Associated with Kidney Function and Prognosis in ANCA-Associated Vasculitis.
2025
Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Outcomes After Kidney Transplantation in Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis.
Outcomes After Kidney Transplantation in Antiglomerular Basement Membrane Disease.
Anti-GBM disease fueled by cardiopulmonary bypass, a lesson for the clinical nephrologist.
Kidney Transplantation Improves Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides With End-Stage Kidney Disease.
Kidney Transplantation Improves Survival in Lupus Nephritis With End-Stage Kidney Disease.
Impact of gender on baseline presentation and outcome in adult IgA vasculitis.
2024
[ANCA-associated vasculitides: what nephrologists need to know].
A predictive mortality score in ANCA-associated renal vasculitis.
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials.
2023
Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis.
[Pathophysiology of ANCA vasculitis].
Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis.
Kidney injury molecule 1 (KIM-1): a potential biomarker of acute kidney injury and tubulointerstitial injury in patients with ANCA-glomerulonephritis.
2022
Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series.
Histopathological prognostic factors in ANCA-associated glomerulonephritis.
Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis.
Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
Patients of 75 years and over with ANCA-associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study.
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
2021
Low Complement C3 Levels at Diagnosis of ANCA-Associated Glomerulonephritis, a Specific Subset of Patients to Target With Anti-C5aR Therapy?: In response to: Hypocomplementemia at Diagnosis of Pauci-immune Glomerulonephritis Is Associated with Advanced Histopathological Activity Index and High Probability of Treatment Resistance (Lionaki et al., Kidney International Reports, June 2021, DOI: 10.1016/j.ekir.2021.05.043).
Impact of aging on phenotype and prognosis in IgA vasculitis.
Commentary: Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
Serum Interleukin-26 Is a New Biomarker for Disease Activity Assessment in Systemic Lupus Erythematosus.
Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients.
Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.
2020
Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Incidence and Risk Factors of Venous Thromboembolic Events in Patients with ANCA-Glomerulonephritis: A Cohort Study from the Maine-Anjou Registry.
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
The Presence of Renal IgG Deposits in Necrotizing Crescentic Glomerulonephritis Associated with ANCA Is Not Related to Worse Renal Clinical Outcomes.
Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside.
2019
T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown.
Clinico-pathological considerations in a 48-years-old female with acute kidney injury: is it lupus nephritis, ANCA-associated vasculitis or something else?
Patients with ANCA-Associated Glomerulonephritis and Connective Tissue Diseases: A Comparative Study from the Maine-Anjou AAV Registry.
2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation.
IgE in lupus pathogenesis: Friends or foes?
2017
Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study.
Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.
Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.
IL-26 Confers Proinflammatory Properties to Extracellular DNA.
2016
IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis.
An Unusual Cause of Abdominal Pain: Lupus Enteritis.
Role of extracellular vesicles in autoimmune diseases.
Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
2015
Patients with dual MPO- and PR3-ANCA do not present primary systemic necrotizing vasculitis.
Emergency testing for antineutrophil cytoplasmic antibodies combined with a dialog-based policy between clinician and biologist: effectiveness for the diagnosis of ANCA-associated vasculitis.
2012
Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Schönlein purpura in adults: a case series.
2011
Necrotizing crescentic immunoglobulin A glomerulonephritis in adult-onset Still's disease.
Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage.
2010
Reversible cerebral vasoconstriction syndrome in a female patient with systemic lupus erythematosus.
2009
Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus.
Bibliographic data retrieved from PubMed (National Library of Medicine). NCBI disclaimer and copyright notice.